ETHYL 5-CHLOROPYRIMIDINE-2-CARBOXYLATE, 95.0%, 500mg

3,5-Diethylbenzoic acid, 25g

2-Bromo-6-chloroimidazo[1,2-b]pyridazine, 95.0%, 250mg

4-Bromoindole, 98.0%, 25g

2,2'-((1,2-Phenylenebis(azanylylidene))bis(methanylylidene))diphenol, 95.0%, 5g

1H,1H,2H,2H-Nonafluorohexyl Acrylate (stabilized with TBC)>98.0%(GC)5g

4-Bromo-5-nitroveratrole, 98.0%, 1g

1-Naphtholphthalein, extra pure, 5 g, glass packaging

DIHYDRO-4-(HYDROXYMETHYL)FURAN-2(3H)-ONE, 95.0%, 1g

5,5'-dithio-bis-(-2-nitrobenzoic acid), min. 98%, pa, 1 g, glass packaging

(3-Formyl-5-propoxyphenyl)boronic acid, 95.0%, 250mg

4-Hydrazinyl-2,6-dimethylpyrimidine, 95+%, 250mg

1-(2-Methoxypyridin-3-yl)ethanone, 95.0%, 1g